Tag: FDA
Browse our exclusive articles!
FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved a new single-injection, once-monthly maintenance option (200 mg/2...
FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted approval for Rybelsus®, the only oral GLP-1 therapy, to reduce...
FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP
Amgen and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has granted approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance therapy...
FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults
Genentech, part of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for adults with active...
FDA Approves Celltrion’s EYDENZELT for Retinal Diseases
Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...
